| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 14 Jun 24 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.02 | 25,000 | 25.50 k | 25,000 |
| 8 Sep 23 | SURF Surface Oncology | Common Stock | Sale back to company | Dispose D | No | No | 0 | 83,193 | 0.00 | 0 |
| 8 Sep 23 | SURF Surface Oncology | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.69 | 400,000 | 276.00 k | 0 |
